|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 8.080 USD | -1.34% |
|
+0.37% | +308.08% |
| 08-10 | ImmunityBio, Inc. Announces Appointment of Dr. Jim Yong Kim as Vice Chairman | CI |
| 08-04 | ImmunityBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 8.56B 7.37B 6.93B 6.33B 11.85B 809B 11.88B 81.93B 31.79B 415B 32.16B 31.46B 1,336B | P/E 2026 * |
-8.42x | P/E 2027 * | -56.7x |
|---|---|---|---|---|---|
| Enterprise Value | 8.56B 7.37B 6.93B 6.33B 11.85B 809B 11.88B 81.93B 31.79B 415B 32.16B 31.46B 1,336B | EV / Sales 2026 * |
37.9x | EV / Sales 2027 * | 19.4x |
| Free-Float |
37.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IBRX | Delayed | |
CBOE
| IBRX | Real-time | |
|
Tradegate
| 26CA | Real-time | |
|
Xetra
| 26CA | Delayed | |
|
Deutsche Boerse AG
| 26CA | Delayed | |
|
Boerse Muenchen
| 26CA | Real-time | |
|
Börse Stuttgart
| 26CA | Delayed |
Last Transcript : ImmunityBio, Inc.
| 1 day | -1.34% | ||
| 1 week | +0.37% | ||
| Current month | +1.64% | ||
| 1 month | +10.38% | ||
| 3 months | +16.76% | ||
| 6 months | -6.81% | ||
| Current year | +308.08% |
| 1 week | 7.73 |  | 8.28 |
| 1 month | 7.42 | | 8.76 |
| Current year | 1.98 | | 12.43 |
| 1 year | 1.95 | | 12.43 |
| 3 years | 1.25 | | 12.43 |
| 5 years | 1.21 | | 12.43 |
| 10 years | 1.21 | | 40.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 57 | 2020-09-30 |
| Chief Executive Officer | 73 | 2015-02-28 | |
David Sachs
DFI | Director of Finance/CFO | 48 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Wesley Clark
BRD | Director/Board Member | 80 | 2021-01-31 |
| Director/Board Member | 71 | 2021-02-28 | |
| Chairman | 73 | 2014-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/26 | Exercice | Director | 243,168 | 0.0232% | ||
| 7/1/26 | Exercice | Director | 478,434 | 0.0457% | ||
| 6/30/26 | Exercice | Director | 3,000 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.34% | +0.37% | +236.67% | +461.11% | 8.56B | |
| -1.79% | -2.27% | +43.23% | +99.78% | 67.98B | |
| -2.06% | -0.18% | +39.67% | +85.24% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +377.83% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -13.58% | 26.06B | |
| +0.49% | +1.19% | +26.78% | +18.09% | 25.74B | |
| -1.46% | +0.42% | +23.61% | -16.76% | 20.09B | |
| -2.96% | -15.21% | +216.20% | +375.70% | 17.16B | |
| +0.12% | -1.45% | -6.93% | +549.01% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +165.57% | 14.62B | |
| Average | -0.86% | +0.27% | +61.43% | +210.20% | 28.77B | |
| Weighted average by Cap. | -1.12% | +0.18% | +43.69% | +151.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 226M 194M 183M 167M 312M 21.31B 313M 2.16B 838M 10.93B 848M 829M 35.23B | 441M 380M 357M 327M 611M 41.68B 612M 4.22B 1.64B 21.39B 1.66B 1.62B 68.89B |
| Net income | -1B -864M -813M -743M -1.39B -94.8B -1.39B -9.61B -3.73B -48.64B -3.77B -3.69B -157B | -150M -129M -122M -111M -208M -14.19B -209M -1.44B -558M -7.28B -564M -552M -23.46B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$8.080 | -1.34% | 4,330,218 |
| 26-09-03 | US$8.190 | +3.02% | 5,271,763 |
| 26-09-02 | US$7.950 | +1.02% | 7,228,321 |
| 26-09-01 | US$7.870 | -1.01% | 6,465,675 |
| 26-08-31 | US$7.950 | -1.24% | 6,881,639 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IBRX Stock
Select your edition
All financial news and data tailored to specific country editions
